We are live on ! Find out more
SIG

Sargent Investment Group Portfolio holdings

AUM $759M
1-Year Est. Return 28.58%
This Fund
S&P 500
This Quarter Est. Return
+31.49%
1 Year Est. Return
+28.58%
3 Year Est. Return
+104.74%
5 Year Est. Return
+107.13%
10 Year Est. Return
–
AUM
$266M
AUM Growth
+$48.8M
Cap. Flow
-$3.25M
Cap. Flow %
-1.22%
Top 10 Hldgs %
41.05%
Holding
154
New
18
Increased
47
Reduced
47
Closed
7

Top Buys

Rank Stock Value
1
CTSO icon
Cytosorbents Corp
CTSO
+$2.09M
2
FTCS icon
First Trust Capital Strength ETF
FTCS
+$1.73M
3
IRM icon
Iron Mountain
IRM
+$870K
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$743K
5
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$566K

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$2.51M
2
ATRS
Antares Pharma, Inc.
ATRS
+$1.75M
3
BOC icon
Boston Omaha
BOC
+$1.17M
4
XYZ
Block Inc
XYZ
+$1.15M
5
EXEL icon
Exelixis
EXEL
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 22.92%
2 Healthcare 20.44%
3 Financials 15.49%
4 Consumer Discretionary 6%
5 Real Estate 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDLZ icon
126
Mondelez International
MDLZ
$80.1B
$253K 0.1%
4,952
– –
VTHR icon
127
Vanguard Russell 3000 ETF
VTHR
$4.81B
$249K 0.09%
1,765
– –
FISV
128
Fiserv Inc
FISV
$28.9B
$247K 0.09%
+2,507
New +$252K
MTNB icon
129
Matinas BioPharma
MTNB
$1.72M
$246K 0.09%
6,291
+2,450
+64% +$93.9K
TTD icon
130
Trade Desk
TTD
$8.31B
$245K 0.09%
+5,700
New +$172K
ABBV icon
131
AbbVie
ABBV
$431B
$234K 0.09%
+2,365
New +$208K
EMR icon
132
Emerson Electric
EMR
$87.5B
$234K 0.09%
+3,817
New +$217K
IBB icon
133
iShares Biotechnology ETF
IBB
$9.53B
$234K 0.09%
+1,703
New +$217K
SPLV icon
134
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
$229K 0.09%
4,575
– –
PM icon
135
Philip Morris
PM
$293B
$227K 0.09%
3,249
-150
-4% -$10.9K
LVS icon
136
Las Vegas Sands
LVS
$29.9B
$226K 0.08%
5,020
– –
NSC icon
137
Norfolk Southern
NSC
$76.9B
$221K 0.08%
+1,290
New +$219K
AMGN icon
138
Amgen
AMGN
$219B
$217K 0.08%
+850
New +$194K
HON icon
139
Honeywell
HON
$76.3B
$215K 0.08%
+1,582
New +$209K
ULTA icon
140
Ulta Beauty
ULTA
$23.2B
$214K 0.08%
+1,050
New +$226K
PAYX icon
141
Paychex
PAYX
$42.7B
$206K 0.08%
+2,700
New +$187K
FCX icon
142
Freeport-McMoran
FCX
$95.5B
$194K 0.07%
+16,850
New +$154K
CGRN
143
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$141K 0.05%
41,450
+1,000
+2% +$2.11K
DB icon
144
Deutsche Bank
DB
$70.7B
$93K 0.03%
10,000
– –
STEX
145
Streamex Corp
STEX
$75.3M
$72K 0.03%
+1,000
New +$87K
NAGE
146
Niagen Bioscience
NAGE
$241M
$54K 0.02%
12,000
-82,000
-87% -$367K
GRCE
147
Grace Therapeutics
GRCE
$34.5M
$25K 0.01%
985
– –
NWL icon
148
Newell Brands
NWL
$2.56B
– –
-35,545
Closed -$472K
PRU icon
149
Prudential Financial
PRU
$41.9B
– –
-4,562
Closed -$238K
WBIG icon
150
WBI BullBear Yield 3000 ETF
WBIG
$31.7M
– –
-14,792
Closed -$327K
3 4 5
6
7

Similar funds

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CFS
Cannon Financial Strategists Athens, Georgia $761M AUM 18.73% 1-Year Est. Return
TVAMP
Tennessee Valley Asset Management Partners Knoxville, Tennessee $757M AUM 14.19% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
GWM
Gibbs Wealth Management Alpharetta, Georgia $762M AUM 18.55% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
JGUA
John G. Ullman & Associates Corning, New York $754M AUM 60.05% 1-Year Est. Return

Sargent Investment Group's Q2 2020 Portfolio in Review

As of Q2 2020, Sargent Investment Group held 154 positions worth $266M, up 22% from $217M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Sargent Investment Group's Q2 2020 filing shows 18 new, 47 increased, 47 reduced and 7 closed positions. Its largest new stake was Gilead Sciences: 5,534 shares worth $421K. The largest sale was Abbott, an estimated $2.51M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Sargent Investment Group's largest Q2 2020 buy was Gilead Sciences: 5,534 shares worth $421K.
  • Sargent Investment Group added most to Cytosorbents Corp in Q2 2020, an estimated $2.09M increase.
  • Sargent Investment Group's biggest Q2 2020 reduction was Abbott, cutting an estimated $2.51M.
  • Sargent Investment Group fully exited WBI BullBear Global Income ETF in Q2 2020, selling an estimated $582K.
  • Sargent Investment Group's ten largest holdings make up 41% of its $266M portfolio in Q2 2020.
  • Sargent Investment Group opened 18 new positions and closed 7 in Q2 2020.
  • Sargent Investment Group's portfolio value rose 22% quarter-over-quarter to $266M.

Based on Sargent Investment Group's 13F filing for Q2 2020, filed 11 Aug 2020.